Genomic differences in breast cancers in African American women identified
the ONA take:
Differences in breast cancer recurrence and survival between African American women and white women are well established; however, what drives those differences is not well known.
In this paper, published online in the Journal of Clinical Oncology, investigators describe genomic differences in the tumors of the two groups of women that may explain those disparities.
The impact of socioeconomic factors such as income, health insurance, and access to health services contributes to disparities in recurrence and survival for African American women with breast cancer. Those factors, however, do not explain the whole difference.
The investigators analyzed whole-exome sequencing data from the National Cancer Institute’s Cancer Genome Atlas culled from the tumors of 105 African American women and 664 white women whose breast cancers were diagnosed between 1988 and 2013.
The five most prevalent tumor-specific mutations were the same for both groups, but more African American women’s tumors were driven by the TP53 mutation and the PIK3CA mutation was more common in the white women’s tumors.
Additional factors were found that suggest more aggressive cancers, such as prevalence of the basal-like and mesenchymal stem-like subtypes and the number of mutations within each tumor, were greater in African American women’s tumors.
Basal subtype tumors or those driven by the TP53 mutation were factors in faster tumor recurrence, and also more likely among African American women.
Differences in breast cancer recurrence and survival between African American women and white women are well established.
- Acupuncture Improves Postoperative Symptoms in Women Undergoing Surgery for Breast Cancer
- Prehabilitation Program Improves Preoperative Fitness in Patients With Colorectal Cancer
- Alcohol Consumption, Particularly White Wine, Associated With Increased Risk of Melanoma
- Combination of Gemcitabine and New CHK1 Inhibitor Is Effective in Soft Tissue Sarcomas
- Omitting RT in Certain Older Women With Early Breast Cancer is Safe
- Walnut Consumption Changes Gut Microbiome, Decreases Growth of Colon Cancer in Mice
- Vaccine Enters Phase I Study for Safety and Effectiveness in Multiple Myeloma
- Timing Chemotherapy Administration to Circadian Rhythm Improves Drug Effectiveness
- New Therapy Blocks Breast Cancer Cells From Entering and Hiding in Bone Marrow to Form Latent Metastases
- Baseline PSA Levels in Midlife Could Predict Risk of Lethal Prostate Cancer
- Community Breast Navigation Program Improved Breast Screening Rates in Underserved African American and Latino Women
- Live-streamed Videos Address End-of-Life Planning, Decision-making
- Metastatic Disease Linked to Patients Reporting Diminished QoL
- History of Bilateral Salpingo-oophorectomy, Hormone Replacement Therapy Are Predictive of Breast Density at Cancer Diagnosis
- Mammographically Occult Contralateral Breast Cancer Detection is Effective With Preoperative MRI
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|